Fourpath Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $614K | Sell |
1,379
-188
| -12% | -$83.7K | 0.1% | 127 |
|
|
2025
Q1 | $760K | Sell |
1,567
-130
| -8% | -$63K | 0.13% | 102 |
|
|
2024
Q4 | $683K | Sell |
1,697
-2
| -0.1% | -$805 | 0.13% | 113 |
|
|
2024
Q3 | $790K | Buy |
1,699
+30
| +2% | +$14K | 0.15% | 106 |
|
|
2024
Q2 | $782K | Sell |
1,669
-161
| -9% | -$75.5K | 0.58% | 37 |
|
|
2024
Q1 | $765K | Sell |
1,830
-75
| -4% | -$31.4K | 0.53% | 42 |
|
|
2023
Q4 | $775K | Sell |
1,905
-136
| -7% | -$55.3K | 0.53% | 40 |
|
|
2023
Q3 | $710K | Sell |
2,041
-56
| -3% | -$19.5K | 0.53% | 41 |
|
|
2023
Q2 | $738K | Sell |
2,097
-32
| -2% | -$11.3K | 0.89% | 36 |
|
|
2023
Q1 | $671K | Sell |
2,129
-27
| -1% | -$8.51K | 0.47% | 54 |
|
|
2022
Q4 | $623K | Sell |
2,156
-71
| -3% | -$20.5K | 0.45% | 57 |
|
|
2022
Q3 | $645K | Sell |
2,227
-596
| -21% | -$173K | 0.44% | 54 |
|
|
2022
Q2 | $795K | Sell |
2,823
-769
| -21% | -$217K | 0.49% | 48 |
|
|
2022
Q1 | $937K | Sell |
3,592
-354
| -9% | -$92.3K | 0.37% | 47 |
|
|
2021
Q4 | $867K | Buy |
+3,946
| New | +$867K | 0.33% | 55 |
|